Skip to main content
NewslettersWatchlist

Ginkgo Bioworks Hldgs Inc(DNA-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low0.7403
Day High0.8210
Open:0.8210
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Here's Why That's Bullish for Both Stocks.
Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
Motley Fool
The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation
Motley Fool
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
Motley Fool
Is Ginkgo Bioworks Stock a Buy?
Motley Fool
3 Pharmaceutical Stocks to Buy Hand Over Fist in March
Motley Fool
Is Ginkgo Bioworks Destined to Be in a "Magnificent Seven" of Healthcare Stocks?
Motley Fool
Why Ginkgo Bioworks Stock Is Sinking Today
Motley Fool
Is Ginkgo Bioworks Stock a Buy Now?
Motley Fool
2 Top Biotech Stocks That Wall Street Thinks Could Soon Double in Value
Motley Fool
2 Cathie Wood Stocks With Jaw-Dropping Growth Potential
Motley Fool
Cathie Wood Just Bought These 3 Biotech Stocks. Should You?
Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought Last Week
Motley Fool
2 Growth Stocks That Could Rocket 144% and 202% Higher This Year, According to Wall Street
Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought This Week
Motley Fool
3 Pricey Stocks I'll Be Watching Like a Hawk in 2024
Motley Fool
Better Growth Investment: Ginkgo Bioworks vs. Shiba Inu
Motley Fool
4 Cathie Wood Stocks Wall Street Thinks Will Skyrocket 83% to 168% in 2024
Motley Fool
2 Growth Stocks That Could Rocket 149% to 210% Higher in 2024, According to Wall Street
Motley Fool
5 Innovative Stocks That Could Score a Win for Your Portfolio in 2024
Motley Fool
This Artificial Intelligence Stock Could Be Like Buying Amazon in 1997
Motley Fool
Could Ginkgo Bioworks Stock Help You Become a Millionaire?
Motley Fool
2 Cathie Wood Stocks That Might Be Smart Buys Right Now
Motley Fool
5 Beaten-Down Stocks That Could Soar in 2024
Motley Fool
3 Dirt-Cheap Stocks to Buy Hand Over Fist Before the End of the Year
Motley Fool
If You Invested $1,000 in Ginkgo Bioworks in 2021, This Is How Much You Would Have Today
Motley Fool
Looking for Growth? 2 Top Stocks to Buy Hand Over Fist
Motley Fool
Where Will Ginkgo Bioworks Be in 5 Years?
Motley Fool
3 Key Trends to Consider in Ginkgo Bioworks' Q3 Earnings Report
Motley Fool
3 Cathie Wood Bargain Buys That Should Be on Your List Too
Motley Fool
Why Ginkgo Bioworks Stock Was Plummeting on Thursday
Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Profile

Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.